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ABSTRACT 
 
Objective: The objective of this study was to describe the medication experiences of Hispanic people living with HIV/AIDS. Specific 
aims were to describe their current medication experiences and to describe how they viewed their medication history in order to 
determine essential themes for improving culturally-appropriate medication therapy management services. 
Methods: A qualitative, phenomenological research methodology was employed. Ten adults living with HIV/AIDS were audiotaped 
during semi-structured, in-depth interviews conducted in Spanish. In addition to audiotaping, field notes were taken. Thematic 
analysis of text was done to obtain themes consistent with the research objectives. Analysis was accomplished in two phases. The 
first phase applied Van Manen’s lifeworld existentials of lived body, lived time, lived relation and lived space as the organizing 
framework for identifying themes. The second phase identified “essential themes” using holistic, selective, and detailed approaches 
that were applied to the themes identified in the first phase.  
Results: The results showed that lifeworld existentials were relevant medication experiences for Hispanic patients living with 
HIV/AIDS and their medication-taking behavior during their lives. Ten themes were identified. From these, we identified an overall 
“essential theme” comprised of: (1) Duality of Living with HIV/AIDS and (2) Primacy of Medications for Hispanic HIV/AIDS patients.  
Conclusions: The findings revealed that the medication taking experiences for Hispanic people living with HIV/AIDS can be described 
in terms of the duality of living with HIV/AIDS as “living dead” patients and in terms of the centrality that medications take in their 
lives, even to the point of a spiritual level.  
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INTRODUCTION 
 
Despite improved access to antiretroviral treatment and care 
in many regions of the world, the AIDS pandemic claimed 2.1 
million lives in 2007 [1].  According to the 2008 UNAIDS 
Report [2], the global epidemic is stabilizing but still is at an 
unacceptably high level. Globally there were an estimated 33 
million (30-36 million) people living with HIV
1
 in 2007. The 
estimated number of people living with HIV in the United 
States (U.S.) at the end of 2003 exceeded 1 million for the 
first time [3]. Due to advances in treatment with highly active 
antiretroviral therapy (HAART) since 1996, persons infected  
                                                 
1 HIV is the human immunodeficiency virus. It is the virus that can 
lead to acquired immune deficiency syndrome, or AIDS. Many 
people do not have any symptoms when they first become infected 
with HIV. AIDS is the late stage of HIV infection, when a person’s 
immune system is severely damaged and has difficulty fighting 
diseases and certain cancers. AIDS is HIV-infected people who have 
fewer than 200 CD4 positive T cells. 
http://www.cdc.gov/hiv/topics/basic/index.htm 
 
 
with HIV are living longer than before and progression to 
AIDS has decreased. [4] 
 
HIV/AIDS is having a devastating impact on the Hispanic
2
 
community, which is the largest minority group in the U.S. 
Over the past 30 years, the Hispanic population exhibited 
tremendous growth in the U.S. Approximately 35.3 million 
individuals were identified as Hispanics, according to U.S. 
Census Data 2000 [5].  
 
From the beginning of the pandemic [6] through December 
2000, 114,019 Hispanic men had been identified as having 
AIDS in the U.S. Of these cases, men who had sex with men 
                                                 
2 “Hispanic” or “Latino” refers to persons who trace their origin or 
descent to Mexico, Puerto Rico, Cuba, Spanish speaking Central and 
South America countries, and other Spanish cultures. Origin can be 
considered as the heritage, nationality group, lineage or country of 
the person or the person’s parents or ancestors before their arrival in 
the United States. People who identify their origin as Hispanic or 
Latino may be of any race (www.census.gov). 
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(MSM) represented 42%, injection-drug users (IDU) 
accounted for 35% and 6% of cases were due to heterosexual 
contact. For adult and adolescent Hispanic women, 
heterosexual contact accounted for the largest proportion 
(47%) of cumulative AIDS cases [5].  
 
A literature review did not identify any information on 
Hispanic populations living with HIV/AIDS related to 
“medication experiences,” as a key factor for developing 
culturally-appropriate medication therapy management 
services. This study narrowed its focus to Minneapolis and St. 
Paul, Minnesota, a metropolitan region known as the Twin 
Cities. This is the first study known to the author that focused 
on describing medication experiences using patients' 
narratives in this minority population in Minnesota. It was 
important to focus on this minority group for the following 
reasons: (1) ethnic minorities have been disproportionately 
affected by HIV/AIDS since the beginning of the pandemic in 
the United States [7]; (2) Hispanics account for a 
disproportionate share of new AIDS diagnoses (incidence of 
adult and adolescent AIDS cases per 100,000 population is 
30.4) [7]; (3) medication experiences of HIV/AIDS treatment 
varies by individual, and medication experiences of this 
particular group, have not previously been studied. In 
addition, inquiry about medication experiences was 
conducted to discern an individual patient’s overall story, as 
opposed to studying singular aspects of medication use (such 
as medication adherence).  
 
HIV/AIDS and the Hispanic Population 
 
There is evidence that supports the notion that an 
understanding of overall experiences for HIV/AIDS patients, 
including beliefs and cultural influences, would be useful. For 
example, according to Talashek *8+, Hispanic adults’ risks of 
HIV infection are increased by cultural beliefs and practices, 
for example, the values of machismo and marianismo, and 
the lack of partner communication and open discussion 
regarding sexuality. Ortiz [9] reported that there are some 
factors, “such as trust, a person’s relationship, social 
situation, perception of stigma, discrimination, and the 
interactions among people that influence when, why, and to 
whom a person may share personal information.” Related to 
Ortiz’s work, Kalichman and Nachimson *10+ proposed that 
“disclosing a potential stigmatizing condition or illness may 
cause the person to lose control over his or her emotions, be 
unable to handle others’ responses, and be rejected for 
telling others.” 
 
Furthermore, Servellen and Lombardi [11] reported that out 
of 85 HIV-positive Latino men and women receiving 
treatment, “emotional or informational support from friends 
and family and quality of patient-provider relationship and 
communications were significantly associated with 
antiretroviral medication adherence behaviors.” Medelson 
[12] proposed that for Mexican American women, “health 
was non-corporeal and transcended the physical body.” In 
addition, Medelson reported that Mexican American women 
often seek support outside of the family network and rely 
heavily on their spirituality to guide them through difficult 
times.  
 
In light of this evidence, our study was based upon the 
investigation of a patient’s overall “medication experience” 
using phenomenology as our approach. These concepts are 
described next.  
 
Medication Experience 
 
The concept of “medication experience” is a patient-centered 
approach that is used to provide direct care to patients based 
on the patient’s medication therapy related needs.  It has 
three dimensions: (1) the patient’s description of the 
medication experience, (2) the medication history and (3) the 
current medication record. The medication experience 
includes the patient’s description of his/her expectations, 
wants, concerns, understanding, preferences, attitudes, 
beliefs, and cultural, ethical, or religious influences on 
medication-taking behavior” *13+. Shoemaker and Ramalho 
de Oliveira (2008) define medication experience “as an 
individual’s subjective experience of taking a medication in 
his/her daily life. It is an encounter that is given meaning 
before it happens and is often a reaction to the symbol that 
medication holds.”*14+ 
 
Phenomenology 
 
The goal of phenomenological human-science research is to 
explore the structure of the human lifeworld, the lived world 
as experienced in every day situations and relations. Dilthey 
*15+ proposed that, “in its most basic form, lived experiences 
involve our immediate, pre-reflective consciousness of life: a 
reflexive or self-given awareness that is, as awareness, 
unaware of itself.” Various thinkers emphasize that primary 
lived experience has a temporal structure: It can never be 
comprehended “in its immediate manifestation, but only 
reflectively as past presence” *16+. 
 
The point of phenomenological research is to have access to 
other people’s experiences and their reflections on those 
experiences in order to be able to come to an understanding 
of the deeper meaning or significance of an aspect of human 
experience, in the context of the whole of human experience.  
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Van Manen identified four fundamental themes within 
phenomenological studies, and refers to them as 
“existentials.” Lived space is felt space. It is largely pre-verbal. 
It is the existential theme that refers us to the world or 
landscape in which human beings move and find themselves 
at home. Lived body refers to the phenomenological fact that 
we are always bodily in the world. Lived time is the time that 
appears to speed up when we enjoy ourselves, or slows down 
when we are anxious. The temporal dimensions of past, 
present and future constitute the horizons of a person’s 
temporal landscape. Lived human relation is the lived 
relation we maintain with other people in the interpersonal 
space that we share with them.  
 
These four existentials can be differentiated, but not 
separated. For the purpose of this study we utilized 
phenomenology to illustrate lived medication experiences for 
Hispanics living with HIV/AIDS. Typically, a sample size 
greater than six is considered adequate for a 
phenomenological study, because phenomenological 
research is an intensive study of the particular [17]. 
 
A question that arises is how patients’ medication 
experiences before or after the HIV/AIDS diagnosis affect 
their lived experiences regarding taking medication. This 
question was addressed by communicating with patients 
living with HIV/AIDS about their medication experiences. 
 
Study Objective and Specific Aims 
 
The objective of this study was to describe the medication 
experiences of Hispanic people living with HIV/AIDS. Specific 
aims were to: (1) describe HIV/AIDS Hispanic patients’ current 
medication experiences, (2) describe how patients view their 
medication histories, and (3) identify “essential themes” that 
could be used to improve culturally appropriate medication 
therapy management services to the Hispanic population 
living with HIV/AIDS. 
 
METHODS 
 
Participants and Settings 
 
Participants for this study were 10 Hispanics living with 
HIV/AIDS who received, or were taking, medications for 
HIV/AIDS. Recruitment was accomplished via flyers and 
brochures placed at a social-services agency bulletin board 
and at a community-health clinic, both located within the 
Twin Cities of Minneapolis/St. Paul, Minnesota. The 
recruitment was done in three months. 
 
Inclusion criteria were Hispanic adults (18 years of age and 
above), diagnosed with HIV/AIDS, experienced taking 
HIV/AIDS medications, and willing to participate as indicated 
by informed consent. Exclusion Criteria were Non-Hispanic 
adults and/or Non- HIV/AIDS diagnosed people. The rationale 
for using adult patients only was that the factors affecting 
children’s medication experiences would be very different 
and need to be studied separately to give justice to the topic.  
 
Data Collection 
 
In preparation for individual interviews, participants were 
given a few examples of questions to think about. At the 
beginning of each interview, the researcher explained the 
purpose of the study, answered questions and an informed-
consent form reviewed and signed by the participant. The 
researcher conducted one audio taped, semi-structured 
interview with each participant in Spanish. Participants were 
asked to reflect on their experiences prior to their interviews. 
Asking the participants to reflect in advance of the interview 
and organize their information in a story format has been 
found to help them recall in significant detail, as well as help 
increase the quality of reported information in terms of detail 
and sequencing of actions and events [18].  
 
Data Analysis 
 
The audio taped interviews were transcribed, verbatim, by 
the researcher and the transcripts were checked for accuracy 
against the tapes. The transcripts were translated into English 
(with back translation to Spanish for validity) by the 
researcher. Overall, analysis applied the following two-
phased approach:  
 
Phase I - Systematizing and Analyzing Text Using Lifeworld 
Existentials. Van Manen’s lifeworld existentials of (1) lived 
space, (2) lived body, (3) lived time and (4) lived human 
relation, were used as the framework for analysis [16].  
 
Phase II - Deriving Essential Themes Using Imaginative 
Variation. This phase of analysis involved isolating and 
differentiating those themes that were essential to 
medication experiences from themes that were incidental. An 
“essential theme” has qualities that make a phenomenon 
(living with HIV/AIDS and taking medication) what it is and 
without which the phenomenon could not be what it is. The 
essence of the experience was derived through the process of 
question-posing and reflecting on the text, and writing and 
rewriting about the common experience that emerged from 
the four lifeworld domains. The approaches used in deriving 
the essential themes were: 
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1. Holistic Approach: The whole text was read and reread 
in this approach and then the question asked of it, 
“what sententious phrase may capture the 
fundamental meaning or main significance of the text 
as a whole?”  
2. Selective Approach: The text was read several times by 
the researcher and the question asked, “What phrases 
or statements seem particularly essential or revealing 
about the phenomenon or experience being 
described?”  
3. Detailed or Line-by-Line Approach: Every single 
sentence or sentence group was examined in this 
approach and the question asked, “What does this 
sentence or sentence group reveal about the 
phenomenon of medication experiences of the 
Hispanics living with HIV/AIDS?” 
 
The researcher reflected on the individual responses of the 
participants, the whole of each participant’s experience, and 
similarities and differences between participants, in order to 
derive themes that most appropriately and accurately 
characterized the phenomenon under study.  
 
Ethical Considerations 
 
The Institutional Review Board of the University of Minnesota 
approved this study. Participants signed the informed 
consent prior to the interview. To guarantee participant 
anonymity, all mention of names and places that 
unintentionally happened during the interview were blocked 
out in the transcripts. The transcripts were numerically coded 
and locked in the office of the researcher.  
 
Considerations of Rigor 
 
Considerations of rigor included credibility, fittingness, and 
auditability [19] and were employed at every stage of the 
study. Credibility pertains to how vivid and faithful the 
description is of the phenomenon. In this study, the two 
primary ways that credibility was achieved was that first, the 
analytical procedures were reviewed in detail by a colleague 
who is a qualitative expert, in order to prevent researcher 
bias and selective inattention and, secondly, by the 
researcher providing rich excerpts from the transcripts in the 
results. 
Fittingness addresses how well the working hypothesis or 
proposition fits into a context other than the one from which 
it was generated. This is done in the discussion section by 
relating the connectedness of the study findings with what 
already was known about the topic. Auditability refers to the 
ability of another investigator to follow the decision or audit 
trail. Steps used in the identification of themes were recorded 
and saved under separate files so that the investigators and 
readers could retrace the trail of the analysis, as needed. 
 
RESULTS 
 
The results of this study revealed the medication experiences 
of Hispanic people living with HIV/AIDS in Minnesota, and it 
was conducted within the organizing framework of Van 
Manen’s lifeworld existentials.  The mean number of years 
for participants being diagnosed with HIV/AIDS disease and 
taking medications was 8 years. The range was from 3 years 
to 14 years. Participants were comprised of seven men and 
three women. Five participants had an HIV diagnosis, and five 
participants had an AIDS diagnosis. 
 
Lifeworld Existential: Lived Body 
 
Participants related their HIV/AIDS medication experience by 
equating it to how it made them feel physically and 
emotionally. There was a constant tension between being 
“undetectable” and being “living dead,” and the need to 
appear normal and healthy. Themes were organized under 
three broad areas. After each theme’s label, there is a 
descriptive excerpt from the participants’ interviews.  Themes 
were labeled as:  
 
1. Invisible Evil and “Mortal” Disease: Leading a Double 
Life 
“It is one of the most serious diseases by far on the 
planet, because it is a disease . . . because it is a 
disease that kills and there is no cure. So far, I am 
undetectable.”  
2. Becoming Accustomed to a New “Horrifying” 
Medication Practice: Introduction and Maintenance 
“This adaptation process of starting to take *the 
medicine] was very difficult, I might say. The truth, it 
was very difficult. The most difficult part was to 
accept the disease in the first place, in the second 
place was to accept taking so much medicine, 
because I never took 25 tablets before.”  
3. Life Change: A New Perception of Normality and 
Health 
 “I am no longer taking *other+ medicines; I mean I 
only take medicines approved by my physician even 
for a cold. If I had to take something I wait for my 
doctor’s approval of a medicine, because I want to 
take care of my health because I don’t want to take 
anything that might affect, might affect the HIV 
medicine I have been taking.” 
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Lifeworld Existential: Lived Human Relation 
 
Participants constructed their HIV/AIDS medication 
experiences by connecting them to how they feel in 
relationship with others including medications. Participants 
described their personal meanings of spirituality, family and 
friends. Again, it is a constant challenge for them to look 
normal and healthy, and to keep their diseases secret.  
 
The four themes we identified were organized under two 
broad areas: spirituality and relationship with family and 
friends. All of the participants were raised in the Catholic faith 
and received some formal and informal education in 
Catholicism. Out of the four themes, three described the 
participants’ spirituality experiences and one described 
relationship with family and friends.  
  
1. Spiritual Isolation: The Disease as Punishment 
“Right now I don’t have a relationship with God, 
because I don’t like it. That means for my lifestyle, 
because I am homosexual, and in my church, the 
Catholic Church doesn’t accept homosexuals. The 
fact is that there is not a relationship, because 
according to my beliefs he will not accept me. I know 
He loves me, but I am not doing right things. Then I 
don’t have a direct spirituality with God now, 
because I am not going to the church. I am not 
praying and I am doing bad things. I know that He is 
at my side, but I don’t love Him. I don’t like this 
relationship, because I feel guilty. Because I was 
doing bad things before I was diagnosed with HIV I 
had begun homosexual . . . sexual relationships and I 
had no relationship with God. I believe in God and I 
know that He is with me, but I am not answering 
Him.” 
2. Leading a Double Spiritual Life: Normality and 
Readiness to Die 
“No. No, we do everything normal. You know, like 
healthy people. We go to the church, to parties, and 
family meetings. I mean, it’s normal, since, since 
they don’t know. I look common to them. I look fine. 
I don’t, don’t have any, any sickness.” 
3. Spirituality: The Primacy of Medication Treatment 
“Because . . . the fact is that I want to control it [the 
HIV/AIDS disease] by purely spiritual means. By 
means of power of God. Because God’s power is like 
. . . the medicines. Medicines have power so much as 
him (God). God has a power, the same power like 
the medicine.”  
4. Living a Double Life: To Have or Not Have a Family 
and New Friends 
“I have no family here. I do not have anybody. And 
there it was different. Now, when they know it is 
going to be different. I believe that it is going to 
continue the same way. I don’t know . . . I don’t 
know yet what reaction they might have when they 
know that I am positive. My relationship with my 
family . . . we are very communicative . . . we are 
very communicative, but I don’t know yet. They 
don’t know *participants’ HIV/AIDS condition+.  
Lifeworld Existential: Lived Time 
Participants constructed their medication experiences by 
dividing their lives into “two eras:” before and after their 
HIV/AIDS diagnosis. In addition, participants described their 
new perception of time centered on their medication 
treatment. They also illustrated changes in their medication 
schedules. Again, there was a constant challenge for the 
participants to look as normal and healthy as they had been 
in the past, or before the HIV/AIDS diagnosis. Two themes 
were found when participants described their lived time and 
these are conceptualized as:  
 
1. Before and after HIV/AIDS: Lack of Knowledge 
Regarding the Disease and Medications  
“Before I was diagnosed, I didn’t suffer from 
anything. Sometimes I would only take pills because 
I had a headache. I would buy them myself. They 
were not prescribed. I would buy . . . like, I would 
buy Advil or aspirin.” 
2. Medication-taking Behavior: New Schedule 
 “I don’t know the names. I have it written. I don’t 
know them. No. I have it written. I have changed 
treatments many times during the past 13 years, but 
I don’t know the names. No, I write them down. I 
don’t remember them. There’s one, there’s one that 
is of 300 milligrams, the other one has 3, 3 pills in 1, I 
don’t know how many milligrams it has.” 
 
Lifeworld Existential: Lived Space 
 
Participants described their lived space experience by dividing 
their space into two settings: inside their bodies and outside 
of their bodies. Inside they were living with HIV/AIDS and 
participants were self-isolated. Outside of their bodies, 
participants considered themselves as looking normal and 
healthy, and they interacted with others on common social 
grounds. In addition, participants described their new 
perception of space centered on their medication treatment. 
 There was one theme observed with regards to participants’ 
perceptions of space: 
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Inside and Outside: Living in a Golden Cage.  
 “I am here because the treatment is free and 
because the medicine is easy to obtain due to the 
insurance. In my country [participant is from Puerto 
Rico], the treatment is not the same and you have to 
wait long time to see your doctors, and to get your 
medicines. Here, there are many good people that 
help us, and attend us fast. In my country, you have 
to wait months before to set up an appointment. 
Due to my disease, I have to remain here in the 
United States. If I didn’t get the virus *HIV/AIDS 
disease+ I wouldn’t be here. I will be in my country.” 
 
The Essential Theme 
 
As described earlier, an “essential theme” has qualities that 
make a phenomenon (living with HIV/AIDS and taking 
medication) what it is and without which the phenomenon 
could not be what it is. The essence of the medication taking 
experiences of Hispanic people living with HIV/AIDS was 
derived through the process of question-posing and reflecting 
on the text, and writing and rewriting about the common 
experience that emerged from the four lifeworld domains 
(summarized in Table 1). During this process reflection on 
individual responses of the participants, the whole of each 
participant’s experience, and similarities and differences 
between participants was conducted in order to derive 
“essential themes” that most appropriately and accurately 
characterized the phenomenon under study. Holistic, 
selective, and detailed analysis approaches were used. From 
this analysis, the essential theme was comprised of: (1) the 
Duality of Living with HIV/AIDS and (2) the Primacy of 
Medication.  
 
Regarding the Duality of Living with HIV/AIDS, participants 
needed to appear well when they knew they were dying, like 
“living dead” individuals. Participants admitted to having a 
deadly disease, but because of the influence of their spiritual 
faith and their Hispanic culture in relation to sexuality and 
illicit-drug use, they perceived the disease as an evil condition 
and accept it as a punishment for the behaviors that led them 
to acquire it. The participants described double lives in 
relation to their bodies, families, friends, and communities. 
These double lives materialized the moment they decided not 
to disclose their secrets to any of the aforementioned parties. 
The duality continued when they realized they were being 
treated as normal and healthy people, which in the short and 
long run is what they want. However, this led them to isolate 
themselves from many of the people who might constitute 
their support group. There was a constant tension between 
being healthy to others on the outside but already dead on 
the inside, creating the duality of being a “living dead” 
person.  
 
Regarding the Primacy of Medication, medication-taking 
behavior was described as a slow and painful process. There 
were a number of reasons for this, including the number of 
pills, as well as the complex instructions that accompany 
them. Side effects were difficult to deal with, but probably 
the most overwhelming aspect was knowing that despite 
enduring the side effects—as painful and stressful as they 
were—the present medications will not cure the disease. It is 
at that point that spiritual background often came into play, 
and they turned the whole process of taking medications into 
a religious ritual on which they focused all their life 
expectations. The medications became the life-provider, thus 
cutting-off the possibility of ever having any other kind of 
spirituality. The only ones who knew about their disease, and 
who also provided them with medications, were their health 
care providers. As a result, participants established a sense of 
family, friend and community relationships with them.  
 
DISCUSSION AND CONCLUSIONS 
 
This study was based on an experience model rather than the 
traditional adherence model which typically compares only 
the extent to which a person’s behavior coincides with 
medical or health instructions [20]. For this study, the focus 
was on study subjects’ “medication experiences” which 
included a patient’s description of his/her expectations, 
wants, concerns, understanding, preferences, attitudes, 
beliefs, and cultural, ethical, or religious influences on 
medication-taking behavior. 
 
The findings revealed that the medication taking experiences 
for Hispanic people living with HIV/AIDS can be described in 
terms of the duality of living with HIV/AIDS as “living dead” 
patients and in terms of the centrality that medications take 
in their lives, even to the point of a spiritual level.  
 
In contrast, Roberts [21] stated that HIV-positive patients 
manage taking medications by using facilitators, such as 
mechanical devices, making a commitment, routinizing, 
health beliefs, social support and professional support. Other 
authors *22+ stated that the “influence of the patient-
provider relationship” is a substantial motivator when taking 
medications by HIV/AIDS patients. 
 
Recommendations for Practitioners Providing Medication 
Therapy Management 
 
In order to accommodate Hispanic people living with 
HIV/AIDS, it is essential that medication therapy management 
practitioners share information and be involved in the care 
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plan with other care providers such as pharmacists, nurses, 
physicians, psychologists, social workers, and case managers. 
Based on the findings of our study, it is essential for health-
care providers to be aware of patients’ beliefs and practices 
to provide culturally competent care.  
 
Many patients, for example, believe in the supremacy of 
medications, because their medications are the only thing 
that keeps them alive. However, patients may take the 
medications according to their own schedule and try to hide 
the medications from others so that they fit within the 
“duality” they experience as they live with HIV/AIDS. 
Therefore, it is important for the practitioner to avail 
him/herself of every opportunity to help patients with proper 
storage and scheduling for taking the medication, and how to 
cope with various side effects.  
 
It is critical for practitioners to speak with patients every time 
they refill their prescriptions and it is equally important that 
the practitioner speak with patients in privacy, since patients 
may be living in duality, not want other people—family, 
friends and community—to be made aware of his or her 
disease. For them it is very important to keep the disease 
secret and separate from other parts of their lives.  
 
Practitioners also could assist patients by inquiring about how 
patients are taking medications—their rituals—as well as 
providing rituals for them, in order to improve adherence. 
Rituals would be helpful and accepted by Hispanic patients. 
An example of ritualizing medication taking is “take one pill at 
7 a.m. with a glass of water, five minutes after your breakfast. 
Take the second pill at 7 p.m. with a glass of water, five 
minutes after your dinner.” Specific information about time, 
place, and actions may be important for developing such 
rituals in patients’ lives. However, it is likely that patients may 
wish to develop rituals that exceed the boundaries of health 
care expertise and may require referral to social and spiritual 
care providers as well.  
 
As it was stated by CDC (2008)[23], it is important for all 
health-care providers to work together as a team in providing 
competent and culturally-appropriate care to their Hispanic 
HIV/AIDS patients. It is also essential for professionals who 
are providing health care to educate themselves about the 
beliefs and practices of their patients. Without this 
understanding, the quality and benefits of care will be 
diminished.  
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Table 1 
Lifeworld Existentials for  
Medication Experiences of Hispanic People Living with HIV/AIDS 
 
 
Lived Body Lived Relation 
 
Lived Time 
 
Lived Space 
1. Invisible Evil Mortal 
Disease: Leading a 
Double Life 
 The Severity of the 
Disease: Mortal 
 Invisible Evil Disease 
 Leading a Double 
Life 
 
1. Spiritual Isolation: The 
Disease as a Punishment 
 Defining Spirituality 
 Isolation from a 
Spiritual Community 
 The Disease as a 
Punishment 
 
1. Before and After 
HIV/AIDS: Lack of 
Knowledge regarding the 
Disease and Medication 
1. Double Space: Inside 
and Outside: 
Living in a Golden Cage 
2. Becoming Accustomed 
to a New Horrifying 
Medication Practice: 
Introduction and 
Maintenance 
 The New Condition 
and Starting 
Treatment: The 
Agony 
 Maintenance. Time 
to Become 
Accustomed: From 
Months to Years or 
Never 
 
2. Leading a Double 
Spiritual Life: Normality 
and Readiness for  
Death 
 Normality 
 Readiness for Death 
 
2. Medication-taking 
Behavior: 
New Schedule 
 
3. Life Change: New 
Normality and Health 
Concepts. 
 Normality 
3. The Primacy of 
Medication Treatment 
 
  
 4. Living a Double Life: 
Disclosing or Not Disclosing 
the Disease. 
 Defining Family 
 Building a New Family 
 Defining Friendship 
  
 
 
  
Original Research POLICY 
 
http://z.umn.edu/INNOVATIONS                              2010, Vol. 1, No. 1, Article 6                      INNOVATIONS in pharmacy   9 
 
REFERENCES 
1. Joint United Nation Programme on HIV/AIDS (UNAIDS) 
and World Health Organization (WHO) 2007. AIDS 
epidemic update: December 2007. Page 7. 
2. Joint United Nation Programme on HIV/AIDS (UNAIDS). 
Report on the global HIV/AIDS epidemic 2008: executive 
summary. December 2008.  Page 7. 
3. Centers for Disease Control (CDC). Cases of HIV Infections 
and AIDS in the United States and Dependent Areas. HIV 
statistics. 2007.  Web site accessed by July 31, 2009. 
Available at: http://www.cdc.gov/hiv 
4. Centers for Disease Control (CDC). Trends in HIV/AIDS 
Diagnoses---33 States, 2001-2004. MMWR. November 
18, 2005/54(45):1149-1153. 
5. Centers for Disease Control (CDC).  HIV/AIDS. Basic 
statistics: Statistics and surveillance. Atlanta: U.S. 
Department of Health and Human Services. 2002. 
Available at: http://www.cdc.gov/hiv 
6. Centers for Disease Control (CDC). MMWR.  The Global 
HIV/AIDS Pandemic.  August 11, 2006/Vol.55/No.31. 
2006. Available at: http://www.cdc.gov/hiv 
7. Centers for Disease Control (CDC). MMWR.  HIV Testing 
Among Racial/Ethnic Minorities—United States, 1999.  
November 30, 2001/50 (47):1054-8. Available at: 
http://www.cdc.gov/hiv 
8. Talashek, M.L., Peragallo, N., Norr, K., & Dancy, B.L. The 
context of risky behaviors for Latino youth. Journal of 
Transcultural Nursing, 15(2), 131-138. 2004.  
9. Ortiz, C.E. Disclosing concerns of Latinas living with 
HIV/AIDS. Journal of Transcultural Nursing, 16(3), 210-
217. 2005. 
10. Kalichman, C., & Nachimson, D. Self-efficacy and 
disclosure of HIV-positive serostatus to sex partners. 
Health Psychol, 18(3), 281- 287. 1999. 
11. Servellen, G.V., & Lombardi, ESupportive relationships 
and medication adherence in HIV-infected, low-income 
Latinos. Western J Nurs Res, 27(8), 1023-1039. 2005. 
12. Mendelson, C. Health perceptions of Mexican American 
women. Journal of Transcultural Nursing, 13(3), 210-217. 
2002. 
13. Cipolle, R.J., Strand, L.M., & Morley, P.C. Pharmaceutical 
care practice: The clinician’s guide (2
nd
 Ed.). New York: 
McGraw-Hill. 2004. 
14. Shoemaker, S.J., Ramalho de Oliveira, D. Understanding 
the meaning of medications for patients:The medication 
Experience.”Pharm World Sci (2008) 30:86-91. 
15. Dilthey, W. Poetry and experience. Selected works, (V). 
Princeton, NJ: Princeton University Press. 1985. 
16. Van Manen, M. Researching lived experience. Human 
science for an action sensitive pedagogy. New York: State 
University of New York Press. 1990. 
17. Sandelowski, M. Rigor or rigor mortis: The problem of 
rigor in qualitative research revisited. Advances in 
Nursing Science, 16(2), 1-8. 1993. 
18. Peden-McAlpine, C. Early recognition of patient 
problems: A hermeneutic journey into understanding 
expert thinking in nursing. Scholarly Inquiry for Nursing 
Practice: An International Journal, 14(3), 191-219. 2000. 
19. Beck, C.T. Qualitative research: The evaluation of its 
credibility, fittingness and auditability. Western J Nurs 
Res, 15(2), 263-266. April 1993. 
20. Haynes, R.B., Taylor, D.W., & Sackett, D.L. (eds.) 
Compliance in health care. Baltimore: Johns Hopkins 
University Press. 1979. 
21. Roberts, K., J., Barriers to and Facilitator of HIV-Positive 
Patients’ Adherence to Antiretroviral Treatment 
Regimens. AIDS Patient Care and STDs. Vol. 14 (3):155-
167. 2000.  
22. Stone, V. E., Clarke, J., Lovell, J., Steger, K., Hirschohorn, 
L., Boswell, S., et all. HIV/AIDS Patients’ Perspectives on 
Adhering to Regimens Containing Protease Inhibitors. 
Journal Gen Intern Med. 1998 September;13 (9): 586-
593. 
23. Centers for Disease Control and Prevention- Division of 
HIV/AIDS Prevention. HIV/AIDS Epidemic and HIV/AIDS 
Prevention in the Hispanic/Latino community: 
Consultation with Leaders from the Latino Community. 
April1-2, 2008. Summary Report  0509. Available at: 
http://www.cdcnpin.org/scripts/HispanicLatino/files/Su
mmaryReport_0509.pdf 
 
 
 
 
